Keratoconus is a disease of the eye that causes gradual weakening and thinning of the cornea. As a result, this can cause visual disturbances such as glare, halos, and overall poor vision. It is a progressive disease that tends to get worse over time.
We are currently enrolling patients in an FDA Clinical trial for Transepithelial (Epi-On) Cross-Linking. This treatment has been used internationally for over 15 years to prevent the progression of Keratoconus. Dr. Goodman has performed over 500 cases of Epi-On Cross-Linking and is an expert in the treatment of corneal ectasia.
The procedure combines Riboflavin eye drops along with the application of ultraviolet light to create a chemical reaction with the intent of strengthening the bonds within the cornea and halting the progression of keratoconus.
Click here to read more information about Cross Linking from the CXLUSA study group!
Request an appointment to find out if you are a candidate for Cross Linking.
2211 Bush St.
San Francisco, CA 94115
